Rx-360 Summary of Guidance for Industry and FDA Staff: Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products
The final guidance replaces draft guidance issued in April 2009 and is from CDRH, CDER and CBER and Office of Combination Products. The guidance describes the information that is to be included in a marketing application where an injection device is used with a drug or biological product. The guidance is divided into three sections: Scientific and Technical Considerations, Content and Format Considerations, and Where Can I Find Additional Detail? The second and third sections take up only 2 pages of the 29 page guidance, with the primary focus on scientific and technical aspects that should be addressed with the regulatory filing.
The Scientific and Technical Considerations includes but is not limited to
- Description: This includes identification of the “injector” indication for use, conditions of use and description of the drug/biologic.
- Design Features: This includes comparison to existing “injectors”, engineering drawing and photos, dose setting and administration, graduation marks and fill lines, visual inspection of the drug or biological product, safety features, human factors design.
- Materials used in the “injector” construction that should address possible leachables and extractables, adsorption of the drug/biological to surfaces, seal integrity and materials corrosion.
- Performance testing general use considerations including biocompatibility, shelf life stability and expiry dating, environmental conditions for use, functional testing.
- Performance Testing with regard to the injector and drug/biological including: dose accuracy, depth and route of injection, and special testing considerations (including extractables and leachables, adsorpables, container closure integrity and specific expiry dating).
- Clinical Considerations in Performance Testing.
- •Sterilization and Sterility Assurance.
- •Cross contamination potential.
- •Labeling.
To view or download the guidance, click here
Related News
-
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled. -
News Biden's $2 billion Biotech Boost
President Biden issues executive order to bolster U.S. biomanufacturing sector. -
News US FDA grants priority review for Eisai and Biogen's Alzheimer's drug
Decision by US drug regulator on lecanemab expected by early next year -
News Panaxia's medical cannabis facility in Malta gains EU-GMP standard
This second facility gives the company a significant power multiplier for export capacity and geographical reach -
News CPHI Discover: Remote excipient audits are on the increase, but we must do more to develop novel excipients
Ahead of the session, Value Added Excipients to Unlock the Potential of APIs, at CPHI Discover on Thursday 18th May – global pharma’s largest ever virtual gathering – we spoke with one of the speakers, Dr Iain Moor... -
News Pharma Explained: What is Quality Risk Management & cGMPs?
Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video presenta... -
News Former FDA Commissioner lays out roadmap for building out excess capacity to deal with pandemic situations
Dr Scott Gottlieb shares insights into COVID-19 vaccine development, the upcoming US election and pharma pricing at the CPHI Festival of Pharma -
News Successful MHRA regulatory inspection for Scottish CMO Symbiosis
Inspection conducted remotely using video-conferencing and an online private document sharing platform.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance